{"entity":{"type":"insider","cik":"0001263200","url":"/insider/0001263200","json_url":"/insider/0001263200.json","name":"MPM BIO VENTURES I LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":8,"first":"2004-07-28","last":"2008-06-23","span_basis":"filed_date"},"name_variants":[{"name":"MPM BIO VENTURES I LLC","source":"filing","n_filings":8,"first_seen":"2004-07-28","last_seen":"2008-06-23"}],"transactions":[{"id":3612974,"accession":"0001209191-08-038435","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-08-038435","line_url":"/filing/0001209191-08-038435#line-5","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT INVESTORS 1999 LLC; STEINMETZ MICHAEL; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; BAB BIO VENTURES LLP; BB BIOVENTURES L P; MPM BIOVENTURES I LP; GADICKE ANSBERT","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":153700.0,"shares_display":"153,700","price_per_share":19.9,"price_display":"19.90","price_state":"stated","total_value":3058630.0,"total_display":"3,058,630.00","shares_owned_after":2120431.0,"shares_owned_after_display":"2,120,431","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-23","scope":"insider"},{"id":3612972,"accession":"0001209191-08-038435","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-038435","line_url":"/filing/0001209191-08-038435#line-4","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT INVESTORS 1999 LLC; STEINMETZ MICHAEL; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; BAB BIO VENTURES LLP; BB BIOVENTURES L P; MPM BIOVENTURES I LP; GADICKE ANSBERT","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":28000.0,"total_display":"28,000.00","shares_owned_after":2118331.0,"shares_owned_after_display":"2,118,331","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-23","scope":"insider"},{"id":3612970,"accession":"0001209191-08-038435","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-038435","line_url":"/filing/0001209191-08-038435#line-3","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT INVESTORS 1999 LLC; STEINMETZ MICHAEL; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; BAB BIO VENTURES LLP; BB BIOVENTURES L P; MPM BIOVENTURES I LP; GADICKE ANSBERT","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":19.91,"price_display":"19.91","price_state":"stated","total_value":9955.0,"total_display":"9,955.00","shares_owned_after":2119931.0,"shares_owned_after_display":"2,119,931","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-23","scope":"insider"},{"id":3612968,"accession":"0001209191-08-038435","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-038435","line_url":"/filing/0001209191-08-038435#line-2","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT INVESTORS 1999 LLC; STEINMETZ MICHAEL; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; BAB BIO VENTURES LLP; BB BIOVENTURES L P; MPM BIOVENTURES I LP; GADICKE ANSBERT","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":19.94,"price_display":"19.94","price_state":"stated","total_value":1994.0,"total_display":"1,994.00","shares_owned_after":2119731.0,"shares_owned_after_display":"2,119,731","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-23","scope":"insider"},{"id":3612966,"accession":"0001209191-08-038435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-038435","line_url":"/filing/0001209191-08-038435#line-1","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"MPM ASSET MANAGEMENT INVESTORS 1999 LLC; STEINMETZ MICHAEL; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; BAB BIO VENTURES LLP; BB BIOVENTURES L P; MPM BIOVENTURES I LP; GADICKE ANSBERT","owner_url":null,"role":"Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":19.92,"price_display":"19.92","price_state":"stated","total_value":1992.0,"total_display":"1,992.00","shares_owned_after":2119831.0,"shares_owned_after_display":"2,119,831","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-19","filed_date":"2008-06-23","scope":"insider"},{"id":2811233,"accession":"0001209191-08-037925","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-037925","line_url":"/filing/0001209191-08-037925#line-4","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"BB BIOVENTURES L P; MPM BIOVENTURES I LP; BAB BIO VENTURES LLP; GADICKE ANSBERT; STEINMETZ MICHAEL; MPM BIO VENTURES I LLC; EVNIN LUKE; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99800.0,"shares_display":"99,800","price_per_share":20.15,"price_display":"20.15","price_state":"stated","total_value":2010970.0,"total_display":"2,010,970.00","shares_owned_after":2276231.0,"shares_owned_after_display":"2,276,231","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-17","filed_date":"2008-06-18","scope":"insider"},{"id":2811227,"accession":"0001209191-08-037925","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-037925","line_url":"/filing/0001209191-08-037925#line-3","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"BB BIOVENTURES L P; MPM BIOVENTURES I LP; BAB BIO VENTURES LLP; GADICKE ANSBERT; STEINMETZ MICHAEL; MPM BIO VENTURES I LLC; EVNIN LUKE; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":20.25,"price_display":"20.25","price_state":"stated","total_value":38475.0,"total_display":"38,475.00","shares_owned_after":2274131.0,"shares_owned_after_display":"2,274,131","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-17","filed_date":"2008-06-18","scope":"insider"},{"id":2811223,"accession":"0001209191-08-037925","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-037925","line_url":"/filing/0001209191-08-037925#line-2","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"BB BIOVENTURES L P; MPM BIOVENTURES I LP; BAB BIO VENTURES LLP; GADICKE ANSBERT; STEINMETZ MICHAEL; MPM BIO VENTURES I LLC; EVNIN LUKE; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.17,"price_display":"20.17","price_state":"stated","total_value":2017.0,"total_display":"2,017.00","shares_owned_after":2276031.0,"shares_owned_after_display":"2,276,031","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-17","filed_date":"2008-06-18","scope":"insider"},{"id":2811220,"accession":"0001209191-08-037925","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-037925","line_url":"/filing/0001209191-08-037925#line-1","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"BB BIOVENTURES L P; MPM BIOVENTURES I LP; BAB BIO VENTURES LLP; GADICKE ANSBERT; STEINMETZ MICHAEL; MPM BIO VENTURES I LLC; EVNIN LUKE; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.16,"price_display":"20.16","price_state":"stated","total_value":2016.0,"total_display":"2,016.00","shares_owned_after":2276131.0,"shares_owned_after_display":"2,276,131","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-17","filed_date":"2008-06-18","scope":"insider"},{"id":3549582,"accession":"0001209191-08-037926","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-28","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":183587.0,"shares_display":"183,587","price_per_share":20.05,"price_display":"20.05","price_state":"stated","total_value":3680919.35,"total_display":"3,680,919.35","shares_owned_after":2473593.0,"shares_owned_after_display":"2,473,593","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549580,"accession":"0001209191-08-037926","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-27","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33666.0,"shares_display":"33,666","price_per_share":20.3,"price_display":"20.30","price_state":"stated","total_value":683419.8,"total_display":"683,419.80","shares_owned_after":2410381.0,"shares_owned_after_display":"2,410,381","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549576,"accession":"0001209191-08-037926","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-26","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":20.32,"price_display":"20.32","price_state":"stated","total_value":508000.0,"total_display":"508,000.00","shares_owned_after":2381040.0,"shares_owned_after_display":"2,381,040","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549574,"accession":"0001209191-08-037926","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-25","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19656.0,"shares_display":"19,656","price_per_share":20.25,"price_display":"20.25","price_state":"stated","total_value":398034.0,"total_display":"398,034.00","shares_owned_after":2449753.0,"shares_owned_after_display":"2,449,753","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549572,"accession":"0001209191-08-037926","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-24","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4341.0,"shares_display":"4,341","price_per_share":20.31,"price_display":"20.31","price_state":"stated","total_value":88165.71,"total_display":"88,165.71","shares_owned_after":2406040.0,"shares_owned_after_display":"2,406,040","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549570,"accession":"0001209191-08-037926","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-23","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3176.0,"shares_display":"3,176","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":64155.2,"total_display":"64,155.20","shares_owned_after":2470117.0,"shares_owned_after_display":"2,470,117","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549568,"accession":"0001209191-08-037926","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-22","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2124.0,"shares_display":"2,124","price_per_share":20.26,"price_display":"20.26","price_state":"stated","total_value":43032.24,"total_display":"43,032.24","shares_owned_after":2447629.0,"shares_owned_after_display":"2,447,629","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549567,"accession":"0001209191-08-037926","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-21","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1850.0,"shares_display":"1,850","price_per_share":20.27,"price_display":"20.27","price_state":"stated","total_value":37499.5,"total_display":"37,499.50","shares_owned_after":2445779.0,"shares_owned_after_display":"2,445,779","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549565,"accession":"0001209191-08-037926","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-20","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":20.4,"price_display":"20.40","price_state":"stated","total_value":24480.0,"total_display":"24,480.00","shares_owned_after":2376840.0,"shares_owned_after_display":"2,376,840","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549563,"accession":"0001209191-08-037926","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-19","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":908.0,"shares_display":"908","price_per_share":20.29,"price_display":"20.29","price_state":"stated","total_value":18423.32,"total_display":"18,423.32","shares_owned_after":2444047.0,"shares_owned_after_display":"2,444,047","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549561,"accession":"0001209191-08-037926","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-18","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":824.0,"shares_display":"824","price_per_share":20.28,"price_display":"20.28","price_state":"stated","total_value":16710.72,"total_display":"16,710.72","shares_owned_after":2444955.0,"shares_owned_after_display":"2,444,955","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549559,"accession":"0001209191-08-037926","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-17","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":20.34,"price_display":"20.34","price_state":"stated","total_value":16272.0,"total_display":"16,272.00","shares_owned_after":2379640.0,"shares_owned_after_display":"2,379,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549557,"accession":"0001209191-08-037926","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-16","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":20.33,"price_display":"20.33","price_state":"stated","total_value":12198.0,"total_display":"12,198.00","shares_owned_after":2380440.0,"shares_owned_after_display":"2,380,440","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549555,"accession":"0001209191-08-037926","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-15","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":548.0,"shares_display":"548","price_per_share":20.22,"price_display":"20.22","price_state":"stated","total_value":11080.56,"total_display":"11,080.56","shares_owned_after":2469569.0,"shares_owned_after_display":"2,469,569","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549553,"accession":"0001209191-08-037926","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-14","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":20.39,"price_display":"20.39","price_state":"stated","total_value":10195.0,"total_display":"10,195.00","shares_owned_after":2378040.0,"shares_owned_after_display":"2,378,040","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549551,"accession":"0001209191-08-037926","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-13","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":20.36,"price_display":"20.36","price_state":"stated","total_value":8144.0,"total_display":"8,144.00","shares_owned_after":2378940.0,"shares_owned_after_display":"2,378,940","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549550,"accession":"0001209191-08-037926","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-12","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":20.43,"price_display":"20.43","price_state":"stated","total_value":6129.0,"total_display":"6,129.00","shares_owned_after":2376340.0,"shares_owned_after_display":"2,376,340","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549548,"accession":"0001209191-08-037926","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-11","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":20.35,"price_display":"20.35","price_state":"stated","total_value":6105.0,"total_display":"6,105.00","shares_owned_after":2379340.0,"shares_owned_after_display":"2,379,340","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549545,"accession":"0001209191-08-037926","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-10","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":20.44,"price_display":"20.44","price_state":"stated","total_value":4088.0,"total_display":"4,088.00","shares_owned_after":2376140.0,"shares_owned_after_display":"2,376,140","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549543,"accession":"0001209191-08-037926","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-9","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":20.38,"price_display":"20.38","price_state":"stated","total_value":4076.0,"total_display":"4,076.00","shares_owned_after":2378540.0,"shares_owned_after_display":"2,378,540","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549541,"accession":"0001209191-08-037926","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-8","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":20.37,"price_display":"20.37","price_state":"stated","total_value":4074.0,"total_display":"4,074.00","shares_owned_after":2378740.0,"shares_owned_after_display":"2,378,740","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549539,"accession":"0001209191-08-037926","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-7","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":20.08,"price_display":"20.08","price_state":"stated","total_value":4016.0,"total_display":"4,016.00","shares_owned_after":2473293.0,"shares_owned_after_display":"2,473,293","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549537,"accession":"0001209191-08-037926","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-6","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160.0,"shares_display":"160","price_per_share":20.24,"price_display":"20.24","price_state":"stated","total_value":3238.4,"total_display":"3,238.40","shares_owned_after":2469409.0,"shares_owned_after_display":"2,469,409","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549535,"accession":"0001209191-08-037926","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-5","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.45,"price_display":"20.45","price_state":"stated","total_value":2045.0,"total_display":"2,045.00","shares_owned_after":2376040.0,"shares_owned_after_display":"2,376,040","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3549532,"accession":"0001209191-08-037926","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-4","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.42,"price_display":"20.42","price_state":"stated","total_value":2042.0,"total_display":"2,042.00","shares_owned_after":2376640.0,"shares_owned_after_display":"2,376,640","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3544230,"accession":"0001209191-08-037926","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-3","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.41,"price_display":"20.41","price_state":"stated","total_value":2041.0,"total_display":"2,041.00","shares_owned_after":2376740.0,"shares_owned_after_display":"2,376,740","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3544228,"accession":"0001209191-08-037926","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-2","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":20.06,"price_display":"20.06","price_state":"stated","total_value":2006.0,"total_display":"2,006.00","shares_owned_after":2473493.0,"shares_owned_after_display":"2,473,493","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3544226,"accession":"0001209191-08-037926","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-037926","line_url":"/filing/0001209191-08-037926#line-1","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; GADICKE ANSBERT; BAB BIO VENTURES LLP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; MPM BIO VENTURES I LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIOVENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9.0,"shares_display":"9","price_per_share":20.46,"price_display":"20.46","price_state":"stated","total_value":184.14,"total_display":"184.14","shares_owned_after":2376031.0,"shares_owned_after_display":"2,376,031","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-06-16","filed_date":"2008-06-18","scope":"insider"},{"id":3996467,"accession":"0001209191-08-009087","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-009087","line_url":"/filing/0001209191-08-009087#line-2","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; MPM BIOVENTURES I LP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; GADICKE ANSBERT; BAB BIO VENTURES LLP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27925.0,"shares_display":"27,925","price_per_share":21.36,"price_display":"21.36","price_state":"stated","total_value":596478.0,"total_display":"596,478.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-02-08","filed_date":"2008-02-11","scope":"insider"},{"id":3996466,"accession":"0001209191-08-009087","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-08-009087","line_url":"/filing/0001209191-08-009087#line-1","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; MPM BIOVENTURES I LP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; GADICKE ANSBERT; BAB BIO VENTURES LLP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36664.0,"shares_display":"36,664","price_per_share":23.02,"price_display":"23.02","price_state":"stated","total_value":844005.28,"total_display":"844,005.28","shares_owned_after":2587168.0,"shares_owned_after_display":"2,587,168","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-02-07","filed_date":"2008-02-11","scope":"insider"},{"id":3420326,"accession":"0001209191-08-008192","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-08-008192","line_url":"/filing/0001209191-08-008192#line-5","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; STEINMETZ MICHAEL; GADICKE ANSBERT; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; EVNIN LUKE; BAB BIO VENTURES LLP; MPM BIO VENTURES I LLC; BB BIOVENTURES L P; MPM BIOVENTURES I LP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27300.0,"shares_display":"27,300","price_per_share":23.86,"price_display":"23.86","price_state":"stated","total_value":651378.0,"total_display":"651,378.00","shares_owned_after":2623832.0,"shares_owned_after_display":"2,623,832","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-02-04","filed_date":"2008-02-06","scope":"insider"},{"id":6916965,"accession":"0001209191-07-028012","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-07-028012","line_url":"/filing/0001209191-07-028012#line-4","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; MPM BIOVENTURES I LP; MPM ASSET MANAGEMENT INVESTORS 1999 LLC; BAB BIO VENTURES NV; MPM BIOVENTURES PARALLEL FUND L P; MPM BIO VENTURES I LLC; BAB BIO VENTURES LLP; STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":277777.0,"shares_display":"277,777","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":2499993.0,"total_display":"2,499,993.00","shares_owned_after":4094500.0,"shares_owned_after_display":"4,094,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-05-02","filed_date":"2007-05-04","scope":"insider"},{"id":1281280,"accession":"0001209191-05-043265","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-05-043265","line_url":"/filing/0001209191-05-043265#line-3","is_derivative":false,"issuer_cik":"0000356830","issuer_name":"OSCIENT PHARMACEUTICALS CORP","issuer_ticker":"OSCI","issuer_name_source":null,"issuer_url":"/issuer/0000356830","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; BAB BIO VENTURES LLP; BAB BIO VENTURES NV; MPM BIO VENTURES PARALLEL FUND L P; MPM ASSET MANAGEMENT INVESTORS 1998 LLC/MA; GADICKE ANSBERT; MPM BIO VENTURES I LLC; MPM BIO VENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Director, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":160000.0,"shares_display":"160,000","price_per_share":2.6615,"price_display":"2.66","price_state":"stated","total_value":425840.0,"total_display":"425,840.00","shares_owned_after":7172050.0,"shares_owned_after_display":"7,172,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-08-17","filed_date":"2005-08-17","scope":"insider"},{"id":1281279,"accession":"0001209191-05-043265","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-043265","line_url":"/filing/0001209191-05-043265#line-2","is_derivative":false,"issuer_cik":"0000356830","issuer_name":"OSCIENT PHARMACEUTICALS CORP","issuer_ticker":"OSCI","issuer_name_source":null,"issuer_url":"/issuer/0000356830","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; BAB BIO VENTURES LLP; BAB BIO VENTURES NV; MPM BIO VENTURES PARALLEL FUND L P; MPM ASSET MANAGEMENT INVESTORS 1998 LLC/MA; GADICKE ANSBERT; MPM BIO VENTURES I LLC; MPM BIO VENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Director, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":2.6424,"price_display":"2.64","price_state":"stated","total_value":396360.0,"total_display":"396,360.00","shares_owned_after":7332050.0,"shares_owned_after_display":"7,332,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-08-16","filed_date":"2005-08-17","scope":"insider"},{"id":1281278,"accession":"0001209191-05-043265","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-05-043265","line_url":"/filing/0001209191-05-043265#line-1","is_derivative":false,"issuer_cik":"0000356830","issuer_name":"OSCIENT PHARMACEUTICALS CORP","issuer_ticker":"OSCI","issuer_name_source":null,"issuer_url":"/issuer/0000356830","owner_cik":null,"owner_name":"EVNIN LUKE; BB BIOVENTURES L P; BAB BIO VENTURES LLP; BAB BIO VENTURES NV; MPM BIO VENTURES PARALLEL FUND L P; MPM ASSET MANAGEMENT INVESTORS 1998 LLC/MA; GADICKE ANSBERT; MPM BIO VENTURES I LLC; MPM BIO VENTURES I LP; STEINMETZ MICHAEL","owner_url":null,"role":"Director, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":2.607,"price_display":"2.61","price_state":"stated","total_value":130350.0,"total_display":"130,350.00","shares_owned_after":7482050.0,"shares_owned_after_display":"7,482,050","ownership_form":"I","is_10b5_1":null,"transaction_date":"2005-08-15","filed_date":"2005-08-17","scope":"insider"},{"id":236350,"accession":"0001209191-04-037837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-04-037837","line_url":"/filing/0001209191-04-037837#line-1","is_derivative":false,"issuer_cik":"0001040662","issuer_name":"IDENIX PHARMACEUTICALS INC","issuer_ticker":"IDIX","issuer_name_source":null,"issuer_url":"/issuer/0001040662","owner_cik":null,"owner_name":"BAB BIO VENTURES NV; STEINMETZ MICHAEL; EVNIN LUKE; MPM BIO VENTURES PARALLEL FUND L P; BB BIOVENTURES L P; MPM BIO VENTURES I LLC; MPM BIO VENTURES I LP; MPM ASSET MANAGEMENT LLC; MPM ASSET MANAGEMENT INVESTORS 1998 LLC/MA; BAB BIO VENTURES LLP","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508371.0,"shares_display":"508,371","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":7117194.0,"total_display":"7,117,194.00","shares_owned_after":4797991.0,"shares_owned_after_display":"4,797,991","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-07-27","filed_date":"2004-07-28","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001301081","name":"Pharmasset Inc","url":"/issuer/0001301081","role":"Ten percent owner, Other","n_filings":6,"first_seen":"2007-05-04","last_seen":"2008-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0000356830","name":"OSCIENT PHARMACEUTICALS CORP","url":"/issuer/0000356830","role":"Other","n_filings":1,"first_seen":"2005-08-17","last_seen":"2005-08-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001093649","name":"IDENIX PHARMACEUTICALS INC","url":"/issuer/0001093649","role":"Ten percent owner","n_filings":1,"first_seen":"2004-07-28","last_seen":"2004-07-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001263200","retrieved_at":"2026-08-21T21:33:12+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}